EP1841326A1 - Activated globular protein and its use in edible compositions - Google Patents
Activated globular protein and its use in edible compositionsInfo
- Publication number
- EP1841326A1 EP1841326A1 EP05796249A EP05796249A EP1841326A1 EP 1841326 A1 EP1841326 A1 EP 1841326A1 EP 05796249 A EP05796249 A EP 05796249A EP 05796249 A EP05796249 A EP 05796249A EP 1841326 A1 EP1841326 A1 EP 1841326A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- activated
- protein
- whey protein
- whey
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 102000034238 globular proteins Human genes 0.000 title claims abstract description 17
- 108091005896 globular proteins Proteins 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 claims abstract description 58
- 238000000034 method Methods 0.000 claims abstract description 30
- 108010010803 Gelatin Proteins 0.000 claims abstract description 20
- 229920000159 gelatin Polymers 0.000 claims abstract description 20
- 239000008273 gelatin Substances 0.000 claims abstract description 20
- 235000019322 gelatine Nutrition 0.000 claims abstract description 20
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 20
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 239000003381 stabilizer Substances 0.000 claims abstract description 7
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 6
- 239000003349 gelling agent Substances 0.000 claims abstract description 6
- 239000002562 thickening agent Substances 0.000 claims abstract description 6
- 235000005974 protein supplement Nutrition 0.000 claims abstract description 5
- 229940116540 protein supplement Drugs 0.000 claims abstract description 5
- 108010046377 Whey Proteins Proteins 0.000 claims description 109
- 235000021119 whey protein Nutrition 0.000 claims description 92
- 102000007544 Whey Proteins Human genes 0.000 claims description 86
- 235000018102 proteins Nutrition 0.000 claims description 66
- 102000004169 proteins and genes Human genes 0.000 claims description 66
- 108090000623 proteins and genes Proteins 0.000 claims description 66
- 239000000047 product Substances 0.000 claims description 32
- 238000010438 heat treatment Methods 0.000 claims description 27
- 235000013336 milk Nutrition 0.000 claims description 21
- 239000008267 milk Substances 0.000 claims description 21
- 210000004080 milk Anatomy 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 16
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 16
- 235000016709 nutrition Nutrition 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 12
- 235000013365 dairy product Nutrition 0.000 claims description 11
- 239000000872 buffer Substances 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 235000021001 fermented dairy product Nutrition 0.000 claims description 8
- 239000006260 foam Substances 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 235000013339 cereals Nutrition 0.000 claims description 4
- 230000036571 hydration Effects 0.000 claims description 4
- 238000006703 hydration reaction Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 235000015872 dietary supplement Nutrition 0.000 claims description 2
- 239000012266 salt solution Substances 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 239000005862 Whey Substances 0.000 description 17
- 239000000843 powder Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 239000000499 gel Substances 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 238000001542 size-exclusion chromatography Methods 0.000 description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 8
- 239000008101 lactose Substances 0.000 description 8
- 235000013618 yogurt Nutrition 0.000 description 8
- 108010076119 Caseins Proteins 0.000 description 7
- 102000011632 Caseins Human genes 0.000 description 7
- 102000008192 Lactoglobulins Human genes 0.000 description 7
- 108010060630 Lactoglobulins Proteins 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 7
- 235000021240 caseins Nutrition 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000020477 pH reduction Effects 0.000 description 6
- 239000012460 protein solution Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000005018 casein Substances 0.000 description 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 5
- 235000018417 cysteine Nutrition 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000012467 final product Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 150000003573 thiols Chemical class 0.000 description 5
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 4
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 description 4
- 108010024636 Glutathione Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001879 gelation Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 235000012209 glucono delta-lactone Nutrition 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000009928 pasteurization Methods 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 238000007614 solvation Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 240000000894 Lupinus albus Species 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002956 ash Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229940021722 caseins Drugs 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 108010028463 kappa-casein glycomacropeptide Proteins 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 239000013580 millipore water Substances 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- 235000020200 pasteurised milk Nutrition 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 238000004451 qualitative analysis Methods 0.000 description 2
- 229940108461 rennet Drugs 0.000 description 2
- 108010058314 rennet Proteins 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000012798 spherical particle Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 241000208199 Buxus sempervirens Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 244000045232 Canavalia ensiformis Species 0.000 description 1
- 241001012508 Carpiodes cyprinus Species 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920002245 Dextrose equivalent Polymers 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 240000004322 Lens culinaris Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 235000010649 Lupinus albus Nutrition 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 235000002096 Vicia faba var. equina Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- ULFUTCYGWMQVIO-PCVRPHSVSA-N [(6s,8r,9s,10r,13s,14s,17r)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl] acetate;[(8r,9s,13s,14s,17s)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentano Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2.C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 ULFUTCYGWMQVIO-PCVRPHSVSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000019543 dairy drink Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 235000005489 dwarf bean Nutrition 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000020998 fat-free dairy product Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 235000021002 low-fat fermented dairy product Nutrition 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000000954 titration curve Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/137—Thickening substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
- A23J3/16—Vegetable proteins from soybean
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
- A23J3/18—Vegetable proteins from wheat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention pertains to activated globular protein preparations, a method for obtaining such preparations and to their use in edible compositions.
- the present invention relates to the use of activated globular protein as a gelling agent, a thickening agent, an emulsifying agent, a stabilizing agent, a whipping agent, a protein supplement and/or gelatin substitute.
- Hydrocolloids such as gelatin, starch or pectin, find an application in various fields of the food and pharmaceutical industry for stabilizing the product and for imparting additional advantageous product properties.
- a protein material that may be used as a stabilizing agent or a supplement in dairy food or drink products.
- This protein material requires, however, a complicated multi- step isolation process, involving a time and cost intensive elution of fractions from an ion exchange medium, while nutritional products, to which such protein material has been added, have not been accepted by the consumers.
- the patent application EP 0 696 426 Al pertains to a process for the preparation of co- precipitate. That enable the production of dairy products with a 100 % dairy composition and thus a product that can be called yogurt, that mean that gelatin has not to be included in the formula.
- a problem of this kind of substitute is that to obtain a final product with an acceptable texture, it is necessary to add about 2 to 6% of co- precipitate.
- Such replacement should not be derived from meat, tendons and/or bone material, and should be capable to be prepared on a large scale at relatively low costs. In addition, such replacement should be easily obtainable according to simple methods.
- an activated whey protein preparation obtainable according to a method comprising the steps of subjecting a low salt solution containing whey proteins to a heat treatment at a temperature in the range of from 68 to 98°C for a time period of from 1 to 240 minutes, and having at least 20 % of accessible thiol groups on the basis of the total amount of thiol groups present in said activated whey protein, and a proportion of soluble aggregates of at least 20 %.
- Such method can be applied for any other globular protein of interest, having a nutritional chemical index superior to gelatin, such as proteins form egg, cereals, oilseeds, or other vegetables.
- Time, temperature and pH combination should be established in order to obtain a percentage of accessible thiol groups of at least 20 % in an upward or stable maximum plateau, (based on the total amount of thiol groups in the protein), having a proportion of high molecular weight soluble aggregates of at least 20 %, and a minimum increase of hydrophobicity of at least 100% when compared to the hydrophobicity of non-treated proteins.
- the present heat activated globular composition enables the stabilisation and/or the formation of gels having at least the same properties that gels formed by using gelatin or gelatin substitute but simultaneously, said preparation can be used at a lower concentration and said preparation has a higher nutritional value.
- the present invention pertains to a natural heat activated globular protein protein polymere characterised in that it has a protein efficiency ratio of at least 100, preferably 110.
- FIG. 1(A.) shows the formation of soluble aggregates and disappearance of native ⁇ - lactoglobulin at 70 0 C at a protein concentration of 1% ; l(B) shows the formation and disappearance of soluble aggregates and disappearance of native ⁇ -lactoglobulin at 70°C at a protein concentration of 4%.
- FIG. 2 is a flow chart of a process for the preparation of a fermented dairy product using the present invention.
- FIG. 3. is a graph illustrating the milk and whey supernatants analysis after ultracentrifugation (lh/lOO.OOOg) by SEC on TSK G 2000 using Phosphate Buffer.
- FIG. 4. is a graph illustrating the milk and whey supernatants analysis after acidification by GDL by SEC on TSK G 2000 using Phosphate Buffer.
- FIG. 5. shows the evolution of the gel strength results on finished products during storage.
- FIG. 6. shows the evolution of Back Extrusion results on finished products during storage.
- FIG. 7 A and C show the structure of the gel as revealed after an immuno-labelling by anti ⁇ LG antibodies; 7 B and D are enlargements of the areas delineated respectively in images A and C.
- globular protein subjected for a particular period (the upward phase or plateau) of time to a temperature in the range of from 68 to 98 0 C, exhibits properties, clearly matching or even exceeding those of conventional gelatin or replacer.
- This material is extremely suitable for use as e.g. a gelling agent, a thickening agent, an emulsifying agent, a stabilizing agent, a whipping agent, a protein supplement and/or gelatin substitute.
- the preparation of the present invention may be used as an adequate replacement for gelatin in, for example, dairy products and in particular in low fat fermented dairy products can be expected to be highly accepted both by the consumers, since no material deemed to be potentially hazardous is utilized, as well as by the producers, since it represents an advantageous additive for the preparation of edible compositions.
- globular protein as used in the present invention, comprises: from milk, egg, from cereals (Barley, Maize, Oats, Rice, Wheat, Sorghum, Millet), from legumes (Chickpea, Lentil, Lima bean, Pea, Field bean), from oilseeds (Cotton, Oilseed rape, Peanut, Sesame, soybean, Sunflower) and from pseudocereals (Buckwheat, Amaranth Quinoa) and also sweet potato isolate, white lupin (L.albus) and locus bean.
- one kind of globular protein can be used but a mixture of globular proteins can also be used.
- any globular proteins in particular those having a PER of at least 100 can be used, but in the following description whey proteins will be used as a preferred embodiment.
- Said whey proteins can be obtained by any process for the preparation of milk whey known in the art, as well as milk whey protein fractions prepared therefrom or the main proteins of milk whey, such as beta-lactoglobulin, alpha-lactalbumin and whey albumin.
- sweet whey obtained as a by-product in cheese manufacture, and acid whey as produced in acid casein manufacture or rennet whey as produced during rennet casein manufacture may be used as the whey protein.
- whey protein preparation which has not been subjected to additional fractionation processes after its production is preferred as starting material.
- the present invention is not restricted to whey isolates from bovine origin, but pertains to whey isolates from all mammalian animal species, such as from sheep, goats, horses, and camels.
- a whey protein may comprise at least 10 wt.-%, preferably 50 wt.-% ⁇ - lactoglobulin and/or 10 wt.-, preferably 20 wt- oc-lactalbumin.
- Whey proteins have a better protein efficiency ratio (PER) compared to casein 118/100
- PER body weight growth (g) / protein weight intake (g).
- Whey protein is an excellent source of essential amino acids (AA) (45%). Rich in AA which requirements may be increased in case of stress and in elderly: compared to casein ( 0.3g cysteine/10Og protein) sweet whey proteins contain 7 times more cysteine and acid whey 10 times more cysteine.
- Cysteine is the rate limiting amino acid for glutathione synthesis
- glutathione is a tripeptide made of glutamate cysteine and glycine. Glutathione has primary important functions in the defense of the body in case of stress.
- activated whey protein preparation pertains to a whey protein preparation that has been subjected to a heat treatment after the isolation of whey protein from the respective precursor material, such as e.g. milk or compositions obtained during a processing of milk to dairy products and that also shows the properties as mentioned above.
- the heat treatment may be a heating step carried out at a temperature of from 68 0 C up to 98°C, preferably of from more than 80 to 95 0 C, even most preferably of from 85 to 95 0 C.
- Tliis preparation is very stable and could be stored in sterile conditions at +4°C during at least 6 months.
- the whey protein, as well as the fractions and/or the major proteins thereof may be used in purified form or likewise in form of a crude product.
- the starting material for the preparation of the activated whey protein preparation is preferably low in divalent cations, the concentration in said cations is preferably less than 2.5% in its powder form, more preferably less than 2%.
- An accessible thiol group according to the present invention is a thiol group that react spontaneously with DTNB reagent without denaturing agent like SDS or urea or guanidine which could be used to determine total thiol content see material and method. (Spectrophotometric Method for Determination of Heat- Activated Sulfhydryl Groups of Skimmilk.Koka, M., Mikolajcid, E.M., Gould, I. A., Dairy Science 51, 217-219 (1968)) The calculation was done in relation to the theoretical protein concentration of 1% or 0.2% and supposing that each molecule of B-LG is able to expose one accessible thiol.
- the activated v ⁇ hey protein preparation according to the present invention has at least 20% of accessible thiol groups, preferably between 35 % and 60 % accessible thiol groups, more preferably between 40 % and 55 % accessible thiol groups.
- the activated whey protein preparation according to the present invention has a proportion of soluble aggregates of at least 20 %.
- Trie proportion of soluble aggregates may be obtained by determining the amount of soluble aggregates by SEC (size exclusion chromatography) (for example measured in gram) and determining the total amount of protein (for example measured in gram) according to the following equation:
- proportion of soluble aggregates amount of soluble aggregates / total amount of protein
- soluble aggregates non sedimented after 30 min centrifugation under 10.00Og, filterable on 0.45 micron filter and eluted in /or close to the exclusion volume corresponding to 1/3 of total volume column (this limit was estimated at 160.000 dalton using gama-globulin for calibration) for a TSK G2000 column used in the following conditions : HPLC analysis was performed on a TSKgel G 2000 SWXL 7.8 mm ID x 30 cm column, using a SWXL 6 mm ID x 4 cm guard column (TosoHaas GmbH, Stuttgart, Germany).
- the column was packed with macroporous silica spherical particles of 5 ⁇ m and 250 A pores.
- the HPLC Agilent 1100 system was composed of a thermostated well-plate sampler (+4°C), column oven (25°C) and DAD detector, set up at 215 ran. Elution was performed in isocratic mode at a flow rate of 0.5 mL min-1 during 40 minutes.
- the elution buffer contained 50 mM NaH 2 PO 4 -H 2 O in Lichrosolv Water (Merck, Darmstadt, Germany) at pH 6.8. The buffer was filtered through 0.45 ⁇ m filters (Millipore).
- the activated whey protein preparation of the present invention has a proportion of soluble aggregates of between 60 % and 100 %, preferably between 65 % and 90 %, more preferably between 70 % and 85 %.
- the activated whey protein preparation shows an increase of surface hydrophobicity of at least 100 % as compared to the protein prior to subjecting it to the heat activation.
- hydrophobicity designates the surface hydrophobicity evaluated by measuring the maxinrun of fluorescence intensity obtained by addition of fluorescent probe (ANS). The more ANS molecules adsorb to protein surface the more signal of fluorescence increase. During heat treatment protein surface interacting with ANS increases.
- the hydrophobicity of the protein may be determined according to the following method: Hydrophobicity was evaluated by spectrofluorometric titration curve to reach the asymptotic fluorescence maximun intencity (Fmax). Adapted from: Bonomi, F., Iametti, S., Pagliarini, E., Peri, C: A spectrofluorimetric approach to the estimation of the surface hydrophobicity modification in milk proteins upon thermal treatment. Milchwissenschaft 43 (5) 281-285 (1998).
- the increase in hydrophobicity in the activated whey protein as compared to the starting whey protein is from 150 % to 300 %, preferably of from 200 % to 300 %, more preferably of from 220 % to 280 %.
- the activated whey protein preparation of the present invention may be present in form of a viscous liquid compatible with pumping from tank to tank and to be integrated- into /mixed with the respective edible composition.
- the activated whey protein preparation may be clear, but also opaque or turbid, depending on the product, into which it is to be integrated/mixed with.
- a gelling of an activated whey protein preparation according to the present invention may be induced by any method known in the art, such as cryo-concentration, phase separation, acidification or calcium addition.
- the whey protein may be present in the aqueous solution in an amount of 0.1 wt.-% to 15 wt.-%, preferably in an amount of 0.2 wt.-% to 12 wt.-%, more preferably in an amount of 0.5 wt-% to 10 wt.-%, in particular in an amount of 2 wt.-% to 8 wt-%.. each on the basis of the total weight of the solution.
- it may be present in the aqueous solution in an amount of 0.1 wt.-% to 12 wt.-%, preferably in an amount of 0.2 wt.-% to 11 wt.-%, each on the basis of the total weight of the solution
- the aqueous solution of the whey protein preparation as present before the activation step may also comprise additional compounds, such as by-products of the respective whey production processes, such as e.g. other proteins (proteose peptones, caseino- glyco-macropeptide (CGMP)), hydrocoloids, or carbohydrates.
- additional compounds such as by-products of the respective whey production processes, such as e.g. other proteins (proteose peptones, caseino- glyco-macropeptide (CGMP)), hydrocoloids, or carbohydrates.
- the amount of " such additional compounds should not exceed 40 wt.-%, preferably 10 wt.-% of the weight of the whey protein contained in the whey protein isolate for ionic charged substances.
- the amount of such additional compounds should not exceed 300 wt.-%, preferably 100 wt- % of the weight of the whey protein contained in the whey protein isolate for non ionic substances like glucose, lactose, maltose, galactose, fructose or maltodextrine with high dextrose equivalent (30-45).
- the protective effect of lactose at a concentration between 5% and 25% can be used to prevent decrease of soluble aggregate and gelation of the whey protein during the heat treatment.
- the heating step is carried out during a time period of 5 to 60 min, preferably between 10 and 30 min. According to a more preferred embodiment the heating step is carried out at a time period of between 14 and 17 min and at a temperature of between 84 0 C and 86 0 C.
- the heating step is, preferably, carried out at a temperature of between more than 80 0 C and up to 98 °C, more preferably between 82°C and 95 0 C, more preferably at a temperature of between 85°C and 92 °C, in particular at a temperature of 92 0 C. It has been shown that temperatures between more than 80 0 C, i.e.
- the heating step is carried out during a time period of 14 to 25 min, preferably between 14 and 20 min. According to a more preferred embodiment the heating step is carried out at a time period of between 14 and 17 min and at a temperature of between 90 C and 95 0 C.
- the process is carried out in an essentially salt free condition, since salt is known to influence the folding and aggregative properties of proteins.
- the present process may also comprise a desalting step of the starting material, which may be effected by methods known in the art to yield a starting material having a salt content of less than about 2.5% of salt, on the basis of the total composition.
- Low salt content allows working at acidic pH below pH 7.0
- additional buffers may be added and/or the pH of the aqueous composition may be adjusted to a pH value in the range of from 6.2 to 8.4, preferably to 6.2 to 7.5, more preferred to a pH of 7.2 to 7.4, in absence or with at least one buffer.
- the buffers may be chosen from the group consisting of acetic acid and salts thereof, such as e.g. sodium acetate or potassium acetate, phosphoric acid and salts thereof, such as e.g. NaH 2 PO 4 , Na 2 HPO 4 , KH 2 PO 4 , K 2 HPO 4 , CH 3 COOH.
- addition of particular buffers to the starting material prior to the heating step allows to tailor properties of the whey protein preparation.
- addition of CH 3 COONaZCH 3 COOH increases the amount of accessible thiols and an increase in hydrophobicity, both of which parameters for the unfolding status of the protein, while addition of Na 2 HPO 4 /NaH 2 PO 4 has been found to favor/increase the percentual formation of soluble aggregates.
- the buffer component(s) may be present in an amount of at least 0.1 wt.-%, preferably in an amount of at least 0.3 wt-%, more preferably in an amount of 0.8 to 2 wt.-%, on the basis of the weight of the total aqueous solution.
- a phosphate buffer prepared with K 2 HPO 4 (MW: 174.18) 50 mM concentration correspond to 8.7g/l (0.87%)
- acetate buffer prepare with acetic acid (CH 3 COOHiMW 60) 50 mM concentration corresponds to 0.3%.
- the present heat activated whey protein according to the present invention improves the nutritional value of the final product because the closest gelatin subsitute having the higher nutritional value is composed by 60% of caseins and 40% of whey proteins. It is well known that the caseins have a nutritional chemical index, PER of 100 and that the whey proteins have a PER of 118. Thus the gelatin substitute of the present invention has a higher nutritional chemical index when it is composed only with whey proteins.
- any kind of food product, food supplement, nutritional composition or pharmaceutical composition in particular in low fat or essentially fat free dairy products, or also where it finds application as a gelling agent, thickening agent, emulsifying agent, stabilizing agent, whipping agent or an agent for mimicking fat, or as a protein supplement and/or gelatin substitute in food or drinkable products.
- examples for products, where the present activated protein may find application are exemplarily yoghurt, fermented milks, milk-based fermented products, mousses, foams, emulsions, ice creams, fermented cereal based products, milk based powders, infant formulae, diet fortifications, pet food, tablets, liquid bacterial suspensions, dried oral supplement, wet oral supplement.
- ⁇ -Lactoglobulin (lot JE002-8-922, 13-12-2000) was obtained from Davisco (Le Sueur, MN, USA). The protein was purified from sweet whey by ultra-filtration and ion exchange chromatography. The composition of the powder is 89.7 % protein, 8.85 % moisture, 1.36% ash (0.079 % Ca 2+ , 0.013 % Mg 2+ , 0.097 % K + , 0.576 % Na + , 0.050 % CF). All other reagents used were of analytical or HPLC grade (Merck Darmstadt, Germany) unless otherwise stated.
- the protein solution was prepared at 0.2% concentration by solvation of ⁇ -lactoglobulin in phosphate buffer 5OmM pH 6.8, and stirring at 20 °C for 2 h.
- the solution was filled in 20 ml glass vials (Agilent Technologies) and sealed with aluminium capsules containing a silicon/PTFE sealing.
- the solution was heated at 68 0 C for 60 min (time to reach the temperature 2.30 - 2.50 min). After the heat treatment, the samples were cooled in ice water to 20 0 C.
- the determination of the accessible thiol groups was done in the samples after heat treatment.
- the concentration of accessible SH was determined using a standard curve (5 to 200 ⁇ M L-Cys). The calculation was done in relation to the theoretical protein concentration of 0.108 mM and supposing that each molecule of B-LG is able to expose one accessible thiol. In those conditions 25.46% of theoretical free thiol content were accessibles.
- Example 2 Preparation of heat activated protein with a commercial solution as starting material
- Whey protein isolate WPI Bipro (Batch JE032- 1-420) was obtained from Davisco (Le Sueur, MN, USA). The composition of the powder is 90.1 % protein, (0.082 % Ca2+, 0.006 % Mg2+, 0.044 % K+, 0.650 % Na+, 0.049 Phosphorus All other reagents used were of analytical or HPLC grade (Merck Darmstadt, Germany) unless otherwise stated.
- the protein solution was prepared at 3.4% protein by solvation of whey protein powder in Millipore water, and stirring at 20 °C for 2 h. The final pH was controlled 7.2.
- the solution was filled in 20 ml glass vials (Agilent Technologies) and sealed with aluminum capsules containing a silicon/PTFE sealing. The solutions were heated at 85 0 C for 15 min (time to reach the temperature 2.30 - 2.50 min). After the heat treatment, the samples were cooled in ice water to 20 °C.
- the HPLC Agilent 1100 system was composed of a thermostated well-plate sampler (+4°C), column oven (25°C) and DAD detector, set up at 215 nm. Elution was performed in isocratic mode at a flow rate of 0.5 mL min-1 during 40 minutes.
- the elution buffer contained 50 mM NaH2PO4 • H2O in Lichrosolv Water (Merck, Darmstadt, Germany) at pH 6.8. The buffer was filtered through 0.45 ⁇ m filters (Millipore).
- the soluble fraction contained 75% of soluble aggregates
- Example 3 Preparation of heat activated protein with a commercial solution as starting material
- Whey protein isolate Prolacta 90 (Batch 989/2) was obtained from from Lactalis( Retier France) The composition of the powder is 87.2 % protein, (0.921 % Ca2+, 0.040 % Mg2+, 0.109 % K+, 0.058 % Na+,0.104% Cl-, 0.232% phosphorus) All other reagents used were of analytical or HPLC grade (Merck Darmstadt, Germany) unless otherwise stated.
- the protein solution was prepared at 3.4% protein by solvation of whey protein powder in Millipore water, and stirring at 20 0 C for 2 h.
- the final pH was controlled 7.0 then adjusted to pH 8.4 by NaOH IN to avoid insoluble aggregate formation during heat treatment.
- the solution was filled in 20 ml glass vials (Agilent Technologies) and sealed with aluminum capsules containing a silicon/PTFE sealing.
- the solutions were heated at 85 0 C for 15 min (time to reach the temperature 2.30 - 2.50 min). After the heat treatment, the samples were cooled in ice water to 20 0 C.
- soluble proteins Determination of soluble proteins.
- the heated whey proteins have been centrifuged at 20 0 C and 26900 g for 15 min.
- the supernatant was used to determine the protein concentration in quartz cuvettes at 280nm. Values are expressed as a percentage of the initial value before heat treatment. For those specific conditions, 100% soluble proteins were obtained.
- Example 4 preparation of acid gel using conventional approach (milk + whey proteins pasteurized together) or invention (pasteurised milk and activated whey proteins).
- Skim milk powder (SMP) and whey protein isolate (WPI) were dispersed in 50 ml water. In order to maintain total solid content stable at 11%, lactose has been added to the samples with a fraction of whey protein (see Table 1). After complete dispersion, volumes were adjusted to 100 ml. Solutions were stirred gently for two hours at room temperature and then stored overnight at 4°C to allow complete hydration. After reconstitution pH were close to 6.6-6.7. AU samples were pasteurized at 85°C for 15 minutes and stored in ice until use.
- Skim milk powder was dispersed in 50 ml water. In order to maintain total solid content stable at 11%, lactose has been added to the samples with a fraction of whey protein (detailed recipes are presented in table 1). After complete dispersion, volumes were adjusted to 83 ml. Solutions were stirred gently for two hours at room temperature and then stored overnight at 4°C to allow complete hydration. Samples were pasteurized at 85°C for 15 minutes, and then cooled down at 4 0 C. Activated whey proteins were added to the desired concentration and the final volume was adjusted to 100 ml with water and stored in ice until utilization.
- Skimmed milk powder was obtained from Ingredia (France) Detailed composition of the powder is: 34% protein, 50.5% lactose, 7.94% ashes, 2.02 % citrate, 4.47 water.
- 2 Whey protein isolate (Bipro ® , batch JE032- 1-420) was obtained from Davisco (Le Sueur, MN, USA). The composition of the powder is 90.1 % protein, (0.082 % Ca 2+ , 0.006 % Mg 2+ , 0.044 % K + , 0.650 % Na + , 0.049 Phosphorus. 3 From a 6% stock solution of activated whey proteins.
- Acid-induced gelation Glucono- ⁇ -lactone (GDL) was added (1.5% w/v) to ice-cold samples. Temperature was increased to 42°C (time zero) and acidification was monitored over time.
- GDL Glucono- ⁇ -lactone
- Example 5 Preparation of a fermented dairy product with activated whey protein preparation and differences compared to the prior art:
- Fermented dairy products with 0.5 w.t.-% activated whey protein were produced and compared to reference samples. Skimmed milk powder was added to adjust the total protein content to 4.3 w.t-% and the total solid content to 11.7%.
- pasteurization of the initial blend liquid rnilk, milk powder and lactose
- HAWP heat activated whey protein solution
- Example 4 a heat activated whey protein solution (HAWP) is prepared as indicated in Example 4 (with a protein content of 10 % and a lactose content of 10%), cooled to 43°C and incorporated to the pasteurized blend just before ferments addition as indicated in Figure 2.
- One recipe with activated proteins defined in the present invention has been compared to a conventional yogurt made with co-precipitate.
- Total protein content was to 5.1 % in the recipe with the co-precipitate for a total solid content of 13.9 % and only 4.3% in the recipe with activated whey proteins (HAWP) for a solid content of 11.7%.
- HAWP activated whey proteins
- the back extrusion represented in the figure 6 illustrates the similarity of the recipes with coprecipitate and heated whey protein.
- Samples produced according to the fermented dairy product preparation method of the present invention provide superior properties when compared to the reference samples.
- Fermented dairy products (yogurts) prepared according the present invention have the following properties compared to the reference (i.e. yogurts with unheated whey protein) - less serum
- yogurts prepared according to the fermented dairy product preparation method of the present invention obtain a more advantageous texture (thickness of product, strength of product), but these products can be also more granular.
- the flavor characteristics of the yogurt are essentially not influenced.
- Yogurts produced according the present invention compared to the usual white base with co-precipitate are very close although the total protein is 14% less than the reference.
- products with activated whey protein remained more grainy but were perceived less powdery than, the product with co-precipitate.
- Example 6 Preparation of a whipped acidic dairy product
- a dispersion of 3 w/w% heat-activated whey proteins (Bipro ® ) prepared as described in example 3 has been mixed to a 1.5 w/w% acacia gum dispersion in water and 14% sucrose.
- the pH of the final mixture was adjusted to 7.0 by means on NaOH or HCl.
- a quantity of 0.5 w/w% of GDL was added to this mixture to produce in situ acidification.
- Concomitant whipping was achieved using a Creamtester or Hobbart mixer for 5 minutes in order to produced foam having an overrun ranging from 50 to 300%.
- the final pH of the aerated product was ranging between 5.0 to 3.6. This whipped product can be used as is or mixed with other ingredients.
- a dispersion of 6 w/w% heat-activated whey proteins (Bipro) prepared as described in example 2 has been mixed to 10 w/w% sunflower oil.
- the pH of the final mixture was adjusted to 7.0 by means on NaOH or HCl.
- a quantity of 1 w/w% of GDL was added to this mixture to produce in situ acidification.
- Concomitant emulsif ⁇ cation was achieved using an Ultra Turrax T25 mixing device at maximum speed for 1.
- the final pH of the emulsified product was ranging between 5.5 to 4.0 after 2 hours. In these conditions, the final product was forming a self-supporting white gel, which could be use as is or submitted to subsequent shearing to produce a more creamy spreadable product.
- Example 8 Microscopic images of a fermented product after immunofluorescent labeling by an anti BLG antibody
- Specimen preparation The specimens were sliced with a razor blade into 1-2 mm thick section and submitted to an overnight chemical fixation in a mixture of acetone (3 parts) and glacial acetic acid (1 part). Then the acetic acid was removed by incubating the sliced in pure acetone (8 hours) and the specimens were processed for embedding in historesin (50 % resin/50 % acetone, overnight) and pure historesin (overniglit). After polymerisation in teflon molds, the specimens were sliced into 4 ⁇ m thin section ( Ultracut, Leica).
- microscopy observations were achieved using the Confocal microscopy LSM510 from Zeiss using the objective x63.
- the protein network looks far coarser and thicker than in the sample submitted to the new process 7(C).
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention pertains to activated globular protein preparations, a method for obtaining such preparations and to their use in edible compositions. In particular, the present invention relates to the use of activated globular protein as a gelling agent, a thickening agent, an emulsifying agent, a stabilizing agent, a whipping agent, a protein supplement and/or gelatin substitute.
Description
Activated globular protein and its use in edible compositions.
The present invention pertains to activated globular protein preparations, a method for obtaining such preparations and to their use in edible compositions. In particular, the present invention relates to the use of activated globular protein as a gelling agent, a thickening agent, an emulsifying agent, a stabilizing agent, a whipping agent, a protein supplement and/or gelatin substitute.
Background of the invention
Hydrocolloids, such as gelatin, starch or pectin, find an application in various fields of the food and pharmaceutical industry for stabilizing the product and for imparting additional advantageous product properties.
Since the occurrence of BSE cases in Europe and also in the US, consumers tend to disapprove proteins and hydrocolloids isolated from bovine meat and bone material, which applies to such kind of materials derived from animal in general as well. In order to meet the consumer's desire to avoid products of animal origin, gelatin has been replaced in most of the nutritional and pharmaceutical products by other ingredients. The said ingredients used for this purpose showed, however, not all of the valuable properties of gelatin so that their use often resulted in a loss of desired textural characteristics in the final product, as well as in the development of product defects over time, which are not considered to be acceptable and eventually resulted in a disapproval of the products by the consumers.
So far, no adequate replacement for gelatin is known. In GB 2 188 526 a protein material is disclosed, that may be used as a stabilizing agent or a supplement in dairy food or drink products. This protein material requires, however, a complicated multi- step isolation process, involving a time and cost intensive elution of fractions from an ion exchange medium, while nutritional products, to which such protein material has been added, have not been accepted by the consumers.
The patent application EP 0 696 426 Al pertains to a process for the preparation of co- precipitate. That enable the production of dairy products with a 100 % dairy composition and thus a product that can be called yogurt, that mean that gelatin has not to be included in the formula. A problem of this kind of substitute is that to obtain a final product with an acceptable texture, it is necessary to add about 2 to 6% of co- precipitate.
Thus, there is still a need in the art to provide a replacement for gelatin showing essentially the same properties, e.g. allowing stabilization of the composition and adaptation of the textural characteristics thereof. Such replacement should not be derived from meat, tendons and/or bone material, and should be capable to be prepared on a large scale at relatively low costs. In addition, such replacement should be easily obtainable according to simple methods.
Summary of the invention
It is an object of the present invention to provide a gelatin substitute with improved nutritional properties.
It is an other object of the present invention to provide a gelatin substitute that shows at least the same physical properties.
It is an other object of the present invention to provide a substitute which is cost efficient by allowing the decrease of the protein concentration without any textural or mouthfeel losses.
The above problem has been solved by providing an activated whey protein preparation obtainable according to a method comprising the steps of subjecting a low salt solution containing whey proteins to a heat treatment at a temperature in the range of from 68 to 98°C for a time period of from 1 to 240 minutes, and having at least 20 % of accessible thiol groups on the basis of the total amount of thiol groups present in said activated whey protein, and a proportion of soluble aggregates of at least 20 %.
Such method can be applied for any other globular protein of interest, having a nutritional chemical index superior to gelatin, such as proteins form egg, cereals, oilseeds, or other vegetables.
Time, temperature and pH combination should be established in order to obtain a percentage of accessible thiol groups of at least 20 % in an upward or stable maximum plateau, (based on the total amount of thiol groups in the protein), having a proportion of high molecular weight soluble aggregates of at least 20 %, and a minimum increase of hydrophobicity of at least 100% when compared to the hydrophobicity of non-treated proteins.
Then, the present heat activated globular composition enables the stabilisation and/or the formation of gels having at least the same properties that gels formed by using gelatin or gelatin substitute but simultaneously, said preparation can be used at a lower concentration and said preparation has a higher nutritional value.
The combination of both last features allows a cost reduction and a nutritional improvement in the final product.
Thus, the present invention pertains to a natural heat activated globular protein protein polymere characterised in that it has a protein efficiency ratio of at least 100, preferably 110. In particular, it pertains to a natural heat activated whey protein protein polymere characterised in that it has a protein efficiency ratio of at least 110.
Brief description of the Figures
FIG. 1(A.) shows the formation of soluble aggregates and disappearance of native β- lactoglobulin at 700C at a protein concentration of 1% ; l(B) shows the formation and disappearance of soluble aggregates and disappearance of native β-lactoglobulin at 70°C at a protein concentration of 4%.
FIG. 2 is a flow chart of a process for the preparation of a fermented dairy product using the present invention.
FIG. 3. is a graph illustrating the milk and whey supernatants analysis after ultracentrifugation (lh/lOO.OOOg) by SEC on TSK G 2000 using Phosphate Buffer.
FIG. 4. is a graph illustrating the milk and whey supernatants analysis after acidification by GDL by SEC on TSK G 2000 using Phosphate Buffer.
FIG. 5. shows the evolution of the gel strength results on finished products during storage.
FIG. 6. shows the evolution of Back Extrusion results on finished products during storage.
FIG. 7 A and C: show the structure of the gel as revealed after an immuno-labelling by anti βLG antibodies; 7 B and D are enlargements of the areas delineated respectively in images A and C.
Detailled description of the invention
During the extensive experiments leading to the present invention, the named inventors surprisingly noted that globular protein subjected for a particular period (the upward phase or plateau) of time to a temperature in the range of from 68 to 98 0C, exhibits properties, clearly matching or even exceeding those of conventional gelatin or replacer.
This material is extremely suitable for use as e.g. a gelling agent, a thickening agent, an emulsifying agent, a stabilizing agent, a whipping agent, a protein supplement and/or gelatin substitute.
Moreover, it also has been found that the heat treatment of a globular protein isolate and subsequent mixing with milk yields a product different from subjecting a mixture of globular protein with milk to a heat treatment.
Hence, the preparation of the present invention may be used as an adequate replacement for gelatin in, for example, dairy products and in particular in low fat fermented dairy products can be expected to be highly accepted both by the consumers, since no material deemed to be potentially hazardous is utilized, as well as by the producers, since it represents an advantageous additive for the preparation of edible compositions.
The term "globular protein" as used in the present invention, comprises: from milk, egg, from cereals (Barley, Maize, Oats, Rice, Wheat, Sorghum, Millet), from legumes (Chickpea, Lentil, Lima bean, Pea, Field bean), from oilseeds (Cotton, Oilseed rape, Peanut, Sesame, soybean, Sunflower) and from pseudocereals (Buckwheat, Amaranth Quinoa) and also sweet potato isolate, white lupin (L.albus) and locus bean.
In the present invention, one kind of globular protein can be used but a mixture of globular proteins can also be used.
In the present invention any globular proteins, in particular those having a PER of at least 100 can be used, but in the following description whey proteins will be used as a preferred embodiment.
Said whey proteins can be obtained by any process for the preparation of milk whey known in the art, as well as milk whey protein fractions prepared therefrom or the main proteins of milk whey, such as beta-lactoglobulin, alpha-lactalbumin and whey albumin. In particular, sweet whey obtained as a by-product in cheese manufacture, and acid whey as produced in acid casein manufacture or rennet whey as produced during rennet casein manufacture may be used as the whey protein. Preferably, in particular under cost aspects, whey protein preparation which has not been subjected to additional fractionation processes after its production is preferred as starting material. The present invention is not restricted to whey isolates from bovine origin, but pertains to whey isolates from all mammalian animal species, such as from sheep, goats, horses, and camels. E.g. a whey protein may comprise at least 10 wt.-%, preferably 50 wt.-% β- lactoglobulin and/or 10 wt.-, preferably 20 wt- oc-lactalbumin.
Whey proteins have a better protein efficiency ratio (PER) compared to casein 118/100
PER = body weight growth (g) / protein weight intake (g).
Examples: PER % Casem casein 3,2 100
Egg 3,8 118
Whey 3,8 118
Whole Soya 2,5 78
Wheat gluten 0,3 9
Whey protein is an excellent source of essential amino acids (AA) (45%). Rich in AA which requirements may be increased in case of stress and in elderly: compared to casein ( 0.3g cysteine/10Og protein) sweet whey proteins contain 7 times more cysteine and acid whey 10 times more cysteine. Cysteine is the rate limiting amino acid for glutathione synthesis, glutathione is a tripeptide made of glutamate cysteine and glycine. Glutathione has primary important functions in the defense of the body in case of stress.
The term "activated whey protein preparation" as used in the present invention, pertains to a whey protein preparation that has been subjected to a heat treatment after the isolation of whey protein from the respective precursor material, such as e.g. milk or compositions obtained during a processing of milk to dairy products and that
also shows the properties as mentioned above. The heat treatment may be a heating step carried out at a temperature of from 68 0C up to 98°C, preferably of from more than 80 to 95 0C, even most preferably of from 85 to 95 0C. Tliis preparation is very stable and could be stored in sterile conditions at +4°C during at least 6 months.
The whey protein, as well as the fractions and/or the major proteins thereof may be used in purified form or likewise in form of a crude product. The starting material for the preparation of the activated whey protein preparation is preferably low in divalent cations, the concentration in said cations is preferably less than 2.5% in its powder form, more preferably less than 2%.
Heat activated whey protein preparation according to the present invention and treated accordingly exhibits at least 20 % of accessible thiol groups, on the basis of the total amount of thiol groups present in said activated whey protein. An accessible thiol group according to the present invention is a thiol group that react spontaneously with DTNB reagent without denaturing agent like SDS or urea or guanidine which could be used to determine total thiol content see material and method. (Spectrophotometric Method for Determination of Heat- Activated Sulfhydryl Groups of Skimmilk.Koka, M., Mikolajcid, E.M., Gould, I. A., Dairy Science 51, 217-219 (1968)) The calculation was done in relation to the theoretical protein concentration of 1% or 0.2% and supposing that each molecule of B-LG is able to expose one accessible thiol.
According to a preferred embodiment, the activated v^hey protein preparation according to the present invention has at least 20% of accessible thiol groups, preferably between 35 % and 60 % accessible thiol groups, more preferably between 40 % and 55 % accessible thiol groups.
Moreover, the activated whey protein preparation according to the present invention has a proportion of soluble aggregates of at least 20 %. Trie proportion of soluble aggregates may be obtained by determining the amount of soluble aggregates by SEC (size exclusion chromatography) (for example measured in gram) and determining the total amount of protein (for example measured in gram) according to the following equation:
proportion of soluble aggregates = amount of soluble aggregates / total amount of protein
We can give a definition of soluble aggregates: non sedimented after 30 min centrifugation under 10.00Og, filterable on 0.45 micron filter and eluted in /or close to the exclusion volume corresponding to 1/3 of total volume column (this limit was estimated at 160.000 dalton using gama-globulin for calibration) for a TSK G2000 column used in the following conditions : HPLC analysis was performed on a TSKgel G 2000 SWXL 7.8 mm ID x 30 cm column, using a SWXL 6 mm ID x 4 cm guard column (TosoHaas GmbH, Stuttgart, Germany). The column was packed with macroporous silica spherical particles of 5 μm and 250 A pores. The HPLC Agilent 1100 system was composed of a thermostated well-plate sampler (+4°C), column oven (25°C) and DAD detector, set up at 215 ran. Elution was performed in isocratic mode at a flow rate of 0.5 mL min-1 during 40 minutes. The elution buffer contained 50 mM NaH2PO4-H2O in Lichrosolv Water (Merck, Darmstadt, Germany) at pH 6.8. The buffer was filtered through 0.45 μm filters (Millipore).
According to a preferred embodiment, the activated whey protein preparation of the present invention has a proportion of soluble aggregates of between 60 % and 100 %, preferably between 65 % and 90 %, more preferably between 70 % and 85 %.
In addition, the activated whey protein preparation shows an increase of surface hydrophobicity of at least 100 % as compared to the protein prior to subjecting it to the heat activation. The term "hydrophobicity" as used in the present invention designates the surface hydrophobicity evaluated by measuring the maxinrun of fluorescence intensity obtained by addition of fluorescent probe (ANS). The more ANS molecules adsorb to protein surface the more signal of fluorescence increase. During heat treatment protein surface interacting with ANS increases.
The hydrophobicity of the protein may be determined according to the following method: Hydrophobicity was evaluated by spectrofluorometric titration curve to reach the asymptotic fluorescence maximun intencity (Fmax). Adapted from: Bonomi, F., Iametti, S., Pagliarini, E., Peri, C: A spectrofluorimetric approach to the estimation of the surface hydrophobicity modification in milk proteins upon thermal treatment. Milchwissenschaft 43 (5) 281-285 (1998).
Preferably, the increase in hydrophobicity in the activated whey protein as compared to the starting whey protein is from 150 % to 300 %, preferably of from 200 % to 300 %, more preferably of from 220 % to 280 %.
The activated whey protein preparation of the present invention may be present in form of a viscous liquid compatible with pumping from tank to tank and to be integrated- into /mixed with the respective edible composition. As desired, the activated whey protein preparation may be clear, but also opaque or turbid, depending on the product, into which it is to be integrated/mixed with. When desired a gelling of an activated whey protein preparation according to the present invention may be induced by any method known in the art, such as cryo-concentration, phase separation, acidification or calcium addition.
Without wishing to be bound to any theory, it is presently assumed that the selection of the specific temperature and time window results in a particular and specific denatured condition of the whey protein (in the upward phase or plateau), which is due to a temperature induced unfolding of the proteinaceous material including a potential interaction with other proteins present.
The whey protein may be present in the aqueous solution in an amount of 0.1 wt.-% to 15 wt.-%, preferably in an amount of 0.2 wt.-% to 12 wt.-%, more preferably in an amount of 0.5 wt-% to 10 wt.-%, in particular in an amount of 2 wt.-% to 8 wt-%.. each on the basis of the total weight of the solution. In case another globular protein is used, it may be present in the aqueous solution in an amount of 0.1 wt.-% to 12 wt.-%, preferably in an amount of 0.2 wt.-% to 11 wt.-%, each on the basis of the total weight of the solution
The aqueous solution of the whey protein preparation as present before the activation step may also comprise additional compounds, such as by-products of the respective whey production processes, such as e.g. other proteins (proteose peptones, caseino- glyco-macropeptide (CGMP)), hydrocoloids, or carbohydrates. The amount of" such additional compounds should not exceed 40 wt.-%, preferably 10 wt.-% of the weight of the whey protein contained in the whey protein isolate for ionic charged substances. The amount of such additional compounds should not exceed 300 wt.-%, preferably 100 wt- % of the weight of the whey protein contained in the whey protein isolate for non ionic substances like glucose, lactose, maltose, galactose, fructose or maltodextrine with high dextrose equivalent (30-45). The protective effect of lactose at a concentration between 5% and 25% can be used to prevent decrease of soluble aggregate and gelation of the whey protein during the heat treatment.
In Phosphate buffer and depending on protein concentration, according to a preferred embodiment, the heating step is carried out during a time period of 5 to 60 min, preferably between 10 and 30 min. According to a more preferred embodiment the heating step is carried out at a time period of between 14 and 17 min and at a temperature of between 84 0C and 86 0C.
In absence of Phosphate buffer (just by adjusting pH by NaOH or HCl and for WPC, WPI with low mineral content especially Ca and Mg, the heating step is, preferably, carried out at a temperature of between more than 80 0C and up to 98 °C, more preferably between 82°C and 95 0C, more preferably at a temperature of between 85°C and 92 °C, in particular at a temperature of 920C. It has been shown that temperatures between more than 80 0C, i.e. about 81 0C and 92 0C lead to activated whey proteins having the above mentioned traits of accessible thiol groups and proportion of soluble aggregates, and which prove to even out compete the properties of commercial milk protein based functional ingredient (co precipitate) as a gelling agent, a thickening agent, an emulsifying agent, a stabilizing agent, or a whipping agent.
In said preferred embodiment, the heating step is carried out during a time period of 14 to 25 min, preferably between 14 and 20 min. According to a more preferred embodiment the heating step is carried out at a time period of between 14 and 17 min and at a temperature of between 90 C and 95 0C.
The process is carried out in an essentially salt free condition, since salt is known to influence the folding and aggregative properties of proteins. Thus the present process may also comprise a desalting step of the starting material, which may be effected by methods known in the art to yield a starting material having a salt content of less than about 2.5% of salt, on the basis of the total composition. Low salt content allows working at acidic pH below pH 7.0
Alternatively, additional buffers may be added and/or the pH of the aqueous composition may be adjusted to a pH value in the range of from 6.2 to 8.4, preferably to 6.2 to 7.5, more preferred to a pH of 7.2 to 7.4, in absence or with at least one buffer. The buffers may be chosen from the group consisting of acetic acid and salts thereof, such as e.g. sodium acetate or potassium acetate, phosphoric acid and salts thereof, such as e.g. NaH2PO4, Na2HPO4, KH2PO4, K2HPO4, CH3COOH.
Surprisingly, the present inventors also noted that addition of particular buffers to the starting material prior to the heating step allows to tailor properties of the whey protein preparation. For example, addition of CH3COONaZCH3COOH increases the amount of
accessible thiols and an increase in hydrophobicity, both of which parameters for the unfolding status of the protein, while addition of Na2HPO4/NaH2PO4 has been found to favor/increase the percentual formation of soluble aggregates.
Depending on molecular weight, The buffer component(s) may be present in an amount of at least 0.1 wt.-%, preferably in an amount of at least 0.3 wt-%, more preferably in an amount of 0.8 to 2 wt.-%, on the basis of the weight of the total aqueous solution. As example a phosphate buffer prepared with K2HPO4 (MW: 174.18) 50 mM concentration correspond to 8.7g/l (0.87%), acetate buffer prepare with acetic acid (CH3COOHiMW 60) 50 mM concentration corresponds to 0.3%.
Finally, inventors note that the present heat activated whey protein according to the present invention improves the nutritional value of the final product because the closest gelatin subsitute having the higher nutritional value is composed by 60% of caseins and 40% of whey proteins. It is well known that the caseins have a nutritional chemical index, PER of 100 and that the whey proteins have a PER of 118. Thus the gelatin substitute of the present invention has a higher nutritional chemical index when it is composed only with whey proteins. It can be used for the preparation of any kind of food product, food supplement, nutritional composition or pharmaceutical composition, in particular in low fat or essentially fat free dairy products, or also where it finds application as a gelling agent, thickening agent, emulsifying agent, stabilizing agent, whipping agent or an agent for mimicking fat, or as a protein supplement and/or gelatin substitute in food or drinkable products. Examples for products, where the present activated protein may find application are exemplarily yoghurt, fermented milks, milk-based fermented products, mousses, foams, emulsions, ice creams, fermented cereal based products, milk based powders, infant formulae, diet fortifications, pet food, tablets, liquid bacterial suspensions, dried oral supplement, wet oral supplement.
The invention is further defined by reference to the following examples describing in detail the preparation of the heat activated proteins of the present invention. The invention described and claimed herein is not to be limited in scope by the specific embodiments herein disclosed, since these embodiments are intended as illustrations of several aspects of the invention. Any equivalent embodiments are intended to be within the scope of this invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from
the foregoing description. Such modifications are also intended to fall within the scope of the appended claims.
Example 1: Preparation of heat activated BLG 0.2% in Phosphate buffer:
β-Lactoglobulin (lot JE002-8-922, 13-12-2000) was obtained from Davisco (Le Sueur, MN, USA). The protein was purified from sweet whey by ultra-filtration and ion exchange chromatography. The composition of the powder is 89.7 % protein, 8.85 % moisture, 1.36% ash (0.079 % Ca2+, 0.013 % Mg2+, 0.097 % K+, 0.576 % Na+, 0.050 % CF). All other reagents used were of analytical or HPLC grade (Merck Darmstadt, Germany) unless otherwise stated.
The protein solution was prepared at 0.2% concentration by solvation of β-lactoglobulin in phosphate buffer 5OmM pH 6.8, and stirring at 20 °C for 2 h. The solution was filled in 20 ml glass vials (Agilent Technologies) and sealed with aluminium capsules containing a silicon/PTFE sealing. The solution was heated at 68 0C for 60 min (time to reach the temperature 2.30 - 2.50 min). After the heat treatment, the samples were cooled in ice water to 20 0C.
The determination of the accessible thiol groups was done in the samples after heat treatment. The 5,5'-Dithiobis (2-nitrobenzoic acid) (3,3 '-6) DTNB solution (5mM) (Fluka, Buchs Switzerland) was prepared in 0.05 M NaH2PO4 buffer at pH 6.8. After mixing 2 ml of the protein solution with 100 μl of the DTNB solution (incubation time: 3 min) at 20 °C, the absorbance was measured at λ=412 nm. The concentration of accessible SH was determined using a standard curve (5 to 200 μM L-Cys). The calculation was done in relation to the theoretical protein concentration of 0.108 mM and supposing that each molecule of B-LG is able to expose one accessible thiol. In those conditions 25.46% of theoretical free thiol content were accessibles.
Example 2 : Preparation of heat activated protein with a commercial solution as starting material
Whey protein isolate WPI Bipro (Batch JE032- 1-420) was obtained from Davisco (Le Sueur, MN, USA). The composition of the powder is 90.1 % protein, (0.082 % Ca2+, 0.006 % Mg2+, 0.044 % K+, 0.650 % Na+, 0.049 Phosphorus All other reagents used were of analytical or HPLC grade (Merck Darmstadt, Germany) unless otherwise stated.
The protein solution was prepared at 3.4% protein by solvation of whey protein powder in Millipore water, and stirring at 20 °C for 2 h. The final pH was controlled 7.2.
The solution was filled in 20 ml glass vials (Agilent Technologies) and sealed with aluminum capsules containing a silicon/PTFE sealing. The solutions were heated at 85 0C for 15 min (time to reach the temperature 2.30 - 2.50 min). After the heat treatment, the samples were cooled in ice water to 20 °C.
Determination of soluble protein and soluble aggregates
After heat treatment, the samples have been centrifuged at 26900 g (Sorvall Instruments RC5C rotor Sorvall SS34) for 15 min and the supernatant was diluted to a protein concentration of ~0.2-2mg/ml. This solution was filtered through 0.45 μm microfilters (Orange Scientific, Waterloo, Belgium), before injection of 25 μL. HPLC analysis was performed on a TSKgel G 2000 SWXL 7.8 mm ID x 30 cm column, using a SWXL 6 mm ID x 4 cm guard column (TosoHaas GmbH, Stuttgart, Germany). The column was packed with macroporous silica spherical particles of 5 μm and 250 A pores. The HPLC Agilent 1100 system was composed of a thermostated well-plate sampler (+4°C), column oven (25°C) and DAD detector, set up at 215 nm. Elution was performed in isocratic mode at a flow rate of 0.5 mL min-1 during 40 minutes. The elution buffer contained 50 mM NaH2PO4 • H2O in Lichrosolv Water (Merck, Darmstadt, Germany) at pH 6.8. The buffer was filtered through 0.45 μm filters (Millipore).
The soluble fraction contained 75% of soluble aggregates
Example 3 : Preparation of heat activated protein with a commercial solution as starting material
Whey protein isolate Prolacta 90 (Batch 989/2) was obtained from from Lactalis( Retier France) The composition of the powder is 87.2 % protein, (0.921 % Ca2+, 0.040 % Mg2+, 0.109 % K+, 0.058 % Na+,0.104% Cl-, 0.232% phosphorus) All other reagents used were of analytical or HPLC grade (Merck Darmstadt, Germany) unless otherwise stated.
The protein solution was prepared at 3.4% protein by solvation of whey protein powder in Millipore water, and stirring at 20 0C for 2 h. The final pH was controlled 7.0 then adjusted to pH 8.4 by NaOH IN to avoid insoluble aggregate formation during heat treatment. The solution was filled in 20 ml glass vials (Agilent Technologies) and sealed with aluminum capsules containing a silicon/PTFE sealing. The solutions were heated at 85
0C for 15 min (time to reach the temperature 2.30 - 2.50 min). After the heat treatment, the samples were cooled in ice water to 20 0C.
Determination of soluble proteins. The heated whey proteins have been centrifuged at 20 0C and 26900 g for 15 min. The supernatant was used to determine the protein concentration in quartz cuvettes at 280nm. Values are expressed as a percentage of the initial value before heat treatment. For those specific conditions, 100% soluble proteins were obtained.
Example 4: preparation of acid gel using conventional approach (milk + whey proteins pasteurized together) or invention (pasteurised milk and activated whey proteins).
Samples were prepared as follow for the conventional approach (milk + whey proteins pasteurized together):
Skim milk powder (SMP) and whey protein isolate (WPI) were dispersed in 50 ml water. In order to maintain total solid content stable at 11%, lactose has been added to the samples with a fraction of whey protein (see Table 1). After complete dispersion, volumes were adjusted to 100 ml. Solutions were stirred gently for two hours at room temperature and then stored overnight at 4°C to allow complete hydration. After reconstitution pH were close to 6.6-6.7. AU samples were pasteurized at 85°C for 15 minutes and stored in ice until use.
Samples were prepared as follow for the Invention (pasteurized milk + activated whey proteins):
Preparation of activated whey proteins solution: 6% whey protein solution in water (Bipro®) was stirred gently for two hours at room temperature and then stored overnight at 4°C to allow complete hydration. After reconstitution, measured pH value was 7.2. The soluble aggregates were obtained by heat treatment at 85°C for 15 minutes and stored in ice until use.
Preparation of the samples: Skim milk powder was dispersed in 50 ml water. In order to maintain total solid content stable at 11%, lactose has been added to the samples with a fraction of whey protein (detailed recipes are presented in table 1). After complete dispersion, volumes were adjusted to 83 ml. Solutions were stirred gently for two hours
at room temperature and then stored overnight at 4°C to allow complete hydration. Samples were pasteurized at 85°C for 15 minutes, and then cooled down at 40C. Activated whey proteins were added to the desired concentration and the final volume was adjusted to 100 ml with water and stored in ice until utilization.
1Skimmed milk powder was obtained from Ingredia (France) Detailed composition of the powder is: 34% protein, 50.5% lactose, 7.94% ashes, 2.02 % citrate, 4.47 water. 2Whey protein isolate (Bipro®, batch JE032- 1-420) was obtained from Davisco (Le Sueur, MN, USA). The composition of the powder is 90.1 % protein, (0.082 % Ca2+, 0.006 % Mg2+, 0.044 % K+, 0.650 % Na+, 0.049 Phosphorus. 3From a 6% stock solution of activated whey proteins.
Acid-induced gelation: Glucono-δ-lactone (GDL) was added (1.5% w/v) to ice-cold samples. Temperature was increased to 42°C (time zero) and acidification was monitored over time.
Characterization of activated whey proteins by size exclusion chromatography (SEC): After centrifugation (Ih, 100.00Og) supernatants were analyzed by SEC. Soluble aggregates are represented by the bottom part of the bar chart (figure 3). Samples prepared by new approach (milk 85°C/15' + soluble aggregates (whey 85°C/15'))
contained up to 10 times more soluble aggregates compare to conventional approach (milk and whey 85°C/15').
After acid-induced gelation, samples were centrifuged (Ih, 100.00Og) and supernatants analyzed by SEC (Figure 4). The strong decrease in soluble aggregates observed for samples prepared by the new approach lead to conclude that soluble aggregates are now involved in the gel structure.
Rheological characterization of acid-induced gels: Small-deformation oscillatory measurements were performed, at a frequency of 1 Hz and strain amplitude of 0.5%, on a controlled-strain rheometer (ARES 100 FRT, Rheonietric Scientific, Piscataway, NJ, USA) equipped with a circulating water bath temperature controller. Couette device with a cup (35 mm diameter) and bob system (33 mm diameter, 35 mm length) was used. Samples were poured directly into the heated measuring system (42°C) of the rheometer. Samples were covered with a thin film of paraffin, oil in order to avoid evaporation during heat treatment. Complex modulus (G*) has been used to represent the solid-like behavior. G* is a representation of both storage modulus (G') and loss modulus (G") according to these equations: G'=G*»cos δ, and G"=G*'sin δ. For a gelled system (G'»>G"), G* could be assimilated to G1 considering that G" and δ are tending towards zero.
As expected from the SEC results for the solution fraction prior acidification (figure 3), obtained gels are firmer with the new process (higher G*). Measured G* values were 882 and 2187 Pa for addition levels of 0.5 and 1.0% of AWP, respectively. For the same addition level, conventional approach is yielding G* values of 538 and 777 Pa (see Figure 4).
Example 5 : Preparation of a fermented dairy product with activated whey protein preparation and differences compared to the prior art:
Preparation of a fermented dairy product with activated whey protein preparation
Fermented dairy products with 0.5 w.t.-% activated whey protein were produced and compared to reference samples. Skimmed milk powder was added to adjust the total protein content to 4.3 w.t-% and the total solid content to 11.7%.
For the preparation of samples according to the present invention, pasteurization of the initial blend (liquid rnilk, milk powder and lactose) was done without added activated whey protein isolates. In parallel, a heat activated whey protein solution (HAWP) is prepared as indicated in Example 4 (with a protein content of 10 % and a lactose content of 10%), cooled to 43°C and incorporated to the pasteurized blend just before ferments addition as indicated in Figure 2.
For control reference samples pasteurization of the blend of all ingredients (liquid milk, milk powder, whey protein isolates and lactose) was done before fermentation. This blend contains 0.5 w.t-% of unheated whey protein and a total content of protein of 4.3 w.t-%.
One recipe with activated proteins defined in the present invention has been compared to a conventional yogurt made with co-precipitate. Total protein content was to 5.1 % in the recipe with the co-precipitate for a total solid content of 13.9 % and only 4.3% in the recipe with activated whey proteins (HAWP) for a solid content of 11.7%.
As shown in the Figure 5, addition of activated whey protein increases the gel strength up to 30% compared to the product with unheated whey protein. Compared to the recipe with the coprecipitate, the gel strength is 1.4 more important with the recipe containing activated whey protein whereas the total protein content is 16% less important.
The back extrusion represented in the figure 6 illustrates the similarity of the recipes with coprecipitate and heated whey protein.
Sensory evaluation
Samples produced according to the fermented dairy product preparation method of the present invention provide superior properties when compared to the reference samples.
Sensory test results show that an addition of whey protein preparation after the pasteurization step results in an increased firmness and thickness compared to the references whatever the concentration added of activated protein (the more the quantity of whey protein, the more increase of texture) .
The following results come from sensory profiles done with a recipe containing 4.4 % of total protein whose 0.5% come from activated whey protein.
Fermented dairy products (yogurts) prepared according the present invention have the following properties compared to the reference (i.e. yogurts with unheated whey protein)
- less serum
- less ropy
- more granular,
- less smooth - more firm
- more sticky
- more thick.
Sensory test show that yogurts prepared according to the fermented dairy product preparation method of the present invention obtain a more advantageous texture (thickness of product, strength of product), but these products can be also more granular. Advantageously, the flavor characteristics of the yogurt are essentially not influenced.
Yogurts produced according the present invention compared to the usual white base with co-precipitate are very close although the total protein is 14% less than the reference. However, products with activated whey protein remained more grainy but were perceived less powdery than, the product with co-precipitate.
Example 6 : Preparation of a whipped acidic dairy product
A dispersion of 3 w/w% heat-activated whey proteins (Bipro®) prepared as described in example 3 has been mixed to a 1.5 w/w% acacia gum dispersion in water and 14% sucrose. The pH of the final mixture was adjusted to 7.0 by means on NaOH or HCl. A quantity of 0.5 w/w% of GDL was added to this mixture to produce in situ acidification. Concomitant whipping was achieved using a Creamtester or Hobbart mixer for 5 minutes in order to produced foam having an overrun ranging from 50 to 300%. The final pH of the aerated product was ranging between 5.0 to 3.6. This whipped product can be used as is or mixed with other ingredients.
Example 7 : Preparation of an acidic dairy "emulgel"
A dispersion of 6 w/w% heat-activated whey proteins (Bipro) prepared as described in example 2 has been mixed to 10 w/w% sunflower oil. The pH of the final mixture was adjusted to 7.0 by means on NaOH or HCl. A quantity of 1 w/w% of GDL was added to this mixture to produce in situ acidification. Concomitant emulsifϊcation was achieved
using an Ultra Turrax T25 mixing device at maximum speed for 1. The final pH of the emulsified product was ranging between 5.5 to 4.0 after 2 hours. In these conditions, the final product was forming a self-supporting white gel, which could be use as is or submitted to subsequent shearing to produce a more creamy spreadable product.
Example 8 : Microscopic images of a fermented product after immunofluorescent labeling by an anti BLG antibody
Specimen preparation The specimens were sliced with a razor blade into 1-2 mm thick section and submitted to an overnight chemical fixation in a mixture of acetone (3 parts) and glacial acetic acid (1 part). Then the acetic acid was removed by incubating the sliced in pure acetone (8 hours) and the specimens were processed for embedding in historesin (50 % resin/50 % acetone, overnight) and pure historesin (overniglit). After polymerisation in teflon molds, the specimens were sliced into 4 μm thin section ( Ultracut, Leica).
Then, the immuno-fluorescence technique was applied to label β-Lactoglobulin (BLG) using rabbit anti-BLG as primary antibody (1/200 in PBS, pH 7.4, overnight) as primary anti-body and FITC labelled goat anti-rabbit gamrna globulins (Sigma, 1/100, 1 hours) as secondary antibody.
The microscopy observations were achieved using the Confocal microscopy LSM510 from Zeiss using the objective x63.
Quantitative analysis
The quantitative analysis was carried out with, the in-house software Colibri. The following parameters were evaluated:
• The area fraction of the network (Vv).
• The surface density of the network (Sv). This parameter quantifies the amount of interfaces between two phases. Higher values indicate higher amount of interface (higher tortuosity) or smaller structures, which is better expressed by normalizing this paramater with the area fraction (Sv/Vv). ® The mean thickness of the protein strands
• The fractal dimension
Results: Qualitative analysis:
The figures 7 highlight two important structural impact of the new process:
In the reference product 7(A), the protein network looks far coarser and thicker than in the sample submitted to the new process 7(C).
In figure 7(C), the plain arrows points to BLG aggregates found in the traditional product, but not in the new one. Moreover, in figure 7(B), the broken arrow highlights the presence of about 200 nm aggregates which form the body of the protein strand, and determine their striated appearance. In the new process such striation is hardly recognizable.
Quantitative analysis:
The results of the uantitative anal sis are iven in the table below:
As can be seen Sv as well as Sv/Vv, and the fractal dimension which are higher in the new product confirm the conclusions of the qualitative analysis. The protein strands are also thinner in the new product.
This study demonstrates clearly that the new process modifies profoundly the structure of the protein network, leading to less aggregated whey proteins.
Claims
1. An activated whey protein preparation, obtainable according to a method comprising the steps of subjecting a low salt solution containing whey proteins to a heat treatment at a temperature in the range of from 68° to 98 0C for a time period of from 1 to 240 minutes, and having at least 20 % of accessible thiol groups on the basis of the total amount of thiol groups present in said activated whey protein, and a proportion of soluble aggregates of at least 20 %.
2. The activated whey protein preparation according to claim 1, wherein said activated whey protein preparation exhibits an increase of hydrophobicity of at least 100 %, when compared to the hydrophobicity of the non-heat treated protein.
3. The activated whey protein preparation according to claim 1 or 2, wherein said activated whey protein has between 30 % and 70 % accessible thiol groups, and/or showing a hydrophobicity having a minimal increase of between 200 % and 300 %, when compared to the hydrophobicity of the non-activated protein, and/or having a proportion of soluble aggregates of between 60 % and 100 °/6.
4 . An activated protein preparation, according to one of claims 1 to 3, wherein the whey protein is replaced by a globular protein, in particular from egg, cereals, oilseeds, or other vegetables.
5. A method for preparing an activated whey protein, said method comprising heating whey protein in a low salt aqueous medium during 10 to 30 min at a temperature of from 75°C to 90 0C.
6. The method according to claim 5, wherein the heating is performed in the presence of at least one component being selected from the group consisting of acetic acid and salts thereof, phosphoric acid and salts.
7. The method according to any of the claims 4 to 6, wherein the mixture of said whey protein in said aqueous medium has prior to the heating step a pH of from 6.2 to 8.4, preferably a pH of 6.6 to 7.4, in absence of at least one buffer component, and/or a pH of 6 to 8, preferably of 6.2 to 7.5 in the presence of at least one buffer component.
8. The method according to any of the claims 4 to 7, wherein said whey protein is present in an amount of 0.1 wt.-% to 15 wt.-%, preferably in an amount of 0.2 wt.-% to 12 wt.-%, more preferably in an amount of 2 wt.-% to 8 wt % each on the basis of the weight of the total weight of the solution.
9. Use of an activated protein according to any of the claims 1 to 4, for the preparation of a food product, a food supplement, a nutritional or pharmaceutical composition.
10. The use according to claim 9, wherein said nutritional or pharmaceutical composition is selected from the group consisting of nutritional foam composition and dairy composition.
11. The use according to claim 9 or 10, wherein said activated protein preparation is used as a gelling agent, thickening agent, emulsifying agent, stabilizing agent, whipping agent or an agent for mimicking fat, or as a protein supplement and/or gelatin substitute in food or drinkable products.
12. A dairy product comprising a heat activated protein preparation according to any of the claims 1 to 4.
13. A foam composition comprising a heat activated protein preparation according to any of the claims 1 to 4.
14. The foam composition according to claim 13, wherein said foam comprises a milk-based matrix and/or comprises at least one gum material and/or at least one polysaccharide, preferably acacia gum.
15. A method for preparing a fermented dairy product, said method comprising the steps of: providing an activated whey protein preparation according to any of the claims
1 to 3, mixing said whey protein preparation with a dairy composition and allowing hydration, inoculating the mixture with a suitable strain for fermentation, and allowing fermentation.
16. The method according to claim 15, further comprising the steps of homogenizing and/or cooling prior to the inoculation step.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05796249A EP1841326A1 (en) | 2004-09-29 | 2005-09-28 | Activated globular protein and its use in edible compositions |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04023178 | 2004-09-29 | ||
PCT/EP2005/010484 WO2006034856A1 (en) | 2004-09-29 | 2005-09-28 | Activated globular protein and its use in edible compositions |
EP05796249A EP1841326A1 (en) | 2004-09-29 | 2005-09-28 | Activated globular protein and its use in edible compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1841326A1 true EP1841326A1 (en) | 2007-10-10 |
Family
ID=34926772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05796249A Withdrawn EP1841326A1 (en) | 2004-09-29 | 2005-09-28 | Activated globular protein and its use in edible compositions |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1841326A1 (en) |
AR (1) | AR051046A1 (en) |
AU (1) | AU2005289071A1 (en) |
BR (1) | BRPI0515936A (en) |
MX (1) | MX2007003633A (en) |
TW (1) | TW200626073A (en) |
WO (1) | WO2006034856A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2731462B1 (en) * | 2011-07-15 | 2015-10-21 | Nestec S.A. | Food-grade blue encapsulate and process for the production thereof |
EP3481219B1 (en) * | 2016-07-07 | 2023-03-08 | DSM IP Assets B.V. | Foam comprising rapeseed protein isolate |
DK3484304T3 (en) | 2016-07-15 | 2020-12-07 | Arla Foods Amba | PROCEDURE FOR THE MANUFACTURE OF CONCENTRATED OR DRIED ACID-ADJUSTABLE WHEAT PROTEIN UNITS AND RELATED COMPOSITIONS AND FOOD PRODUCTS |
EP3300606A1 (en) * | 2016-09-28 | 2018-04-04 | DMK Deutsches Milchkontor GmbH | Foamable milk composition |
FR3059208B1 (en) * | 2016-11-29 | 2021-06-18 | Groupe Lactalis | NUTRITIONAL COMPOSITION CONSISTING OF WHEY PROTEINS OR SOLUBLE MILK PROTEINS STABLE TO THERMAL TREATMENT, AND METHOD FOR PREPARING SUCH A COMPOSITION |
FR3122553A1 (en) * | 2021-05-07 | 2022-11-11 | Biogroupe | FOISONNE VEGETABLE WHITE |
WO2023247547A1 (en) | 2022-06-20 | 2023-12-28 | Arla Foods Amba | Agglomerates of soluble whey protein aggregates and medical uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3723407A (en) * | 1972-04-13 | 1973-03-27 | Swift & Co | Method of preparing vegetable protein concentrates |
CH630243A5 (en) * | 1978-05-11 | 1982-06-15 | Nestle Sa | PROCESS FOR RECOVERY OF WHEY PROTEINS. |
US4500454A (en) * | 1982-12-03 | 1985-02-19 | Stauffer Chemical Company | Vegetable protein evidencing improved solution viscosity |
ES2054928T3 (en) * | 1988-07-16 | 1994-08-16 | Westfalia Separator Ag | PROCEDURE FOR THE PRODUCTION OF CHEESE CURD FROM GROSS MILK. |
CA2060655A1 (en) * | 1990-05-17 | 1991-11-18 | Chun-Shun Fang | Proteinaceous fat substitute |
NL9101127A (en) * | 1991-06-28 | 1993-01-18 | Friesland Frico Domo Coop | METHOD FOR PREPARING A PRODUCT LIKE SKIMMED MILK |
US5350590A (en) * | 1992-12-15 | 1994-09-27 | Beatreme Foods Inc. | Protein fat replacer and method of manufacture thereof |
NL9202245A (en) * | 1992-12-23 | 1994-07-18 | Ver Coop Melkind | Process for preparing an adjustable viscosity emulsion; the emulsion and foodstuff thus prepared obtained using this emulsion. |
US5393550A (en) * | 1993-04-15 | 1995-02-28 | Nurture, Inc. | Fat substitute |
DE19711805A1 (en) * | 1996-03-27 | 1998-09-24 | New Zealand Milk Products Euro | Modified milk-based whey cheese and dessert products |
US6465037B1 (en) * | 2000-02-29 | 2002-10-15 | Protein Technologies International, Inc. | Process for producing a novel soy functional food ingredient |
AU2001256186A1 (en) * | 2000-03-06 | 2001-09-17 | Campina Melkunie B.V. | Protein preparation |
US20020051843A1 (en) * | 2000-07-24 | 2002-05-02 | Baker Lois A. | High-foaming, stable modified whey protein isolate |
US6355296B1 (en) * | 2001-02-28 | 2002-03-12 | Protein Technologies International, Inc. | Functional food ingredient |
JP4380117B2 (en) * | 2002-07-19 | 2009-12-09 | 不二製油株式会社 | Tablet containing soybean 7S protein |
-
2005
- 2005-09-28 BR BRPI0515936-9A patent/BRPI0515936A/en not_active IP Right Cessation
- 2005-09-28 MX MX2007003633A patent/MX2007003633A/en not_active Application Discontinuation
- 2005-09-28 EP EP05796249A patent/EP1841326A1/en not_active Withdrawn
- 2005-09-28 AU AU2005289071A patent/AU2005289071A1/en not_active Abandoned
- 2005-09-28 WO PCT/EP2005/010484 patent/WO2006034856A1/en active Application Filing
- 2005-09-29 TW TW094134010A patent/TW200626073A/en unknown
- 2005-09-29 AR ARP050104123A patent/AR051046A1/en unknown
Non-Patent Citations (1)
Title |
---|
See references of WO2006034856A1 * |
Also Published As
Publication number | Publication date |
---|---|
TW200626073A (en) | 2006-08-01 |
AR051046A1 (en) | 2006-12-13 |
WO2006034856A1 (en) | 2006-04-06 |
MX2007003633A (en) | 2007-06-13 |
AU2005289071A1 (en) | 2006-04-06 |
BRPI0515936A (en) | 2008-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Anema | The whey proteins in milk: Thermal denaturation, physical interactions, and effects on the functional properties of milk | |
Fox et al. | Milk proteins | |
EP1841326A1 (en) | Activated globular protein and its use in edible compositions | |
Jovanović et al. | Whey proteins-properties and possibility of application | |
Kamal-Eldin et al. | Physicochemical, rheological, and micro-structural properties of yogurts produced from mixtures of camel and bovine milks | |
Ramos et al. | Effect of composition of commercial whey protein preparations upon gelation at various pH values | |
JP2015529092A (en) | Aggregation of at least one plant protein and at least one milk protein | |
Bottomley et al. | Whey proteins | |
Hussain et al. | From high milk protein powders to the rehydrated dispersions in variable ionic environments: A review | |
JPH0279940A (en) | Endible plastic composition | |
AU2004263068A1 (en) | Production of milk protein ingredient with high whey protein content | |
Zhao et al. | Addition of buttermilk powder improved the rheological and storage properties of low‐fat yogurt | |
Jørgensen et al. | Fractionation by microfiltration: Effect of casein micelle size on composition and rheology of high protein, low fat set yoghurt | |
Li et al. | Interaction between added whey protein ingredients and native milk components in non-fat acidified model systems | |
Patel et al. | Milk protein concentrates: Manufacturing and applications | |
EP1659874A1 (en) | Production of protein composition from a dairy stream and its use as an ingredient in the manufacture of a cheese | |
WO2016129998A1 (en) | Method for preparing an aqueous dispersion of a poorly dispersible plant protein | |
Andiç et al. | Milk proteins: Functionality and use in food industry | |
US20080305208A1 (en) | Dairy Ingredient - Preparation and Use | |
Carr et al. | Protein hydration and viscosity of dairy fluids | |
Augustin et al. | Use of blends of skim milk and sweet whey protein concentrates in reconstituted yogurt | |
EP2034849A1 (en) | Improving of texture of dairy products | |
US20030078392A1 (en) | Milk and cheese modification process, including methods of extracting beta-lactoglobulin and caseins from milk and milk products, and novel products thereby produced | |
NZ526704A (en) | Albumin, heat-denatured, so that it can be a fat replacement with reduced risk of coagulation and/or hydrolysis | |
Corredig | Protein-protein interactions in food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070502 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100401 |